Skip to main content
50°
Rain
Site search
Search
Menu
Search
Subscribe
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
Contact Us
Subscribe
News
East Greenwich Pendulum
Kent County Daily Times
Narragansett Times
NK Standard-Times
Sports
Features
Special Sections
Local Guide
Local Events
Markets & Stocks
Weather
Classifieds
Place ad
Legal Notices
Place Kent Legal
Place SRI Class Legal
Search SRI Legals
Search Kent Legals
Obituaries
Subscribe
E-Edition
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Arcturus Therapeutics Holdings Inc
(NQ:
ARCT
)
32.53
-0.33 (-1.00%)
Streaming Delayed Price
Updated: 11:35 AM EDT, Mar 28, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Arcturus Therapeutics Holdings Inc
< Previous
1
2
3
4
5
6
7
8
9
Next >
A Preview Of Arcturus Therapeutics's Earnings
March 27, 2023
Via
Benzinga
Arcturus Therapeutics to Report Fourth Quarter and Full Year 2022 Financial Results and Provide Corporate Update on March 28, 2023
March 07, 2023
From
Arcturus Therapeutics Holdings Inc.
Via
Business Wire
Arcturus Therapeutics to Attend Upcoming Investor Conferences
February 06, 2023
From
Arcturus Therapeutics Holdings Inc.
Via
Business Wire
Arcturus Therapeutics Announces Clinical Trial Application for ARCT-032 Received Approval to Proceed into First-in-Human Studies to Treat Cystic Fibrosis
January 31, 2023
From
Arcturus Therapeutics Holdings Inc.
Via
Business Wire
Arcturus Therapeutics's Return On Capital Employed Overview
December 15, 2022
Via
Benzinga
Why Arcturus Therapeutics Stock Is Skyrocketing Today
November 02, 2022
Investors are applauding Arcturus' collaboration with CSL.
Via
The Motley Fool
Arcturus Therapeutics to Present at the 41st Annual J.P. Morgan Healthcare Conference
December 19, 2022
From
Arcturus Therapeutics Holdings Inc.
Via
Business Wire
Arcturus Appoints John Markels, Ph.D. to its Board of Directors
December 13, 2022
From
Arcturus Therapeutics Holdings Inc.
Via
Business Wire
Why CSL Ltd Stock Could Be Worth a Look
December 03, 2022
FDA approval of costly--but worthwhile--drug leads the momentum that could make CSL Ltd an equally worthwhile investment.
Via
MarketBeat
Exposures
Product Safety
Benzinga's Top Ratings Upgrades, Downgrades For November 10, 2022
November 10, 2022
Upgrades
Via
Benzinga
Arcturus Therapeutics Announces Third Quarter 2022 Financial Update and Pipeline Progress
November 09, 2022
From
Arcturus Therapeutics Holdings Inc.
Via
Business Wire
Arcturus Therapeutics to Present at the Following Investor Conferences in November
November 07, 2022
From
Arcturus Therapeutics Holdings Inc.
Via
Business Wire
United Therapeutics, Super Micro Computer, Novo Nordisk And Other Big Gainers From Wednesday
November 03, 2022
U.S. stocks closed lower on Wednesday, with the Dow Jones dropping more than 500 points. Here is the list of some big stocks recording gains in the previous session.
Via
Benzinga
Where Arcturus Therapeutics Stands With Analysts
November 02, 2022
Arcturus Therapeutics (NASDAQ:ARCT) has observed the following analyst ratings within the last quarter:
Via
Benzinga
Arcturus Shares Jump After Collaboration With CSL For mRNA-Based Vaccines
November 02, 2022
Via
Benzinga
Why Tupperware Brands Shares Dipped Around 42%; Here Are 89 Biggest Movers From Yesterday
November 03, 2022
Gainers Starry Group Holdings, Inc. (NYSE: STRY) rose 55.6% to close at $0.28 on Wednesday after reporting Q3 results.
Via
Benzinga
Why Benefitfocus Shares Are Trading Higher By Around 48%? Here Are 64 Stocks Moving In Wednesday's Mid-Day Session
November 02, 2022
Gainers Starry Group Holdings, Inc. (NYSE: STRY) gained 56% to $0.2808 after reporting Q3 results.
Via
Benzinga
Why Is Rogers Corporation (ROG) Stock Down 44% Today?
November 02, 2022
Rogers Corporation (ROG) stock is falling hard on Wednesday following confirmation that DuPont (DD) no longer plans to acquire the company.
Via
InvestorPlace
Why Is Benefitfocus (BNFT) Stock Up 48% Today?
November 02, 2022
Benefitfocus (BNFT) stock is rocketing higher on Wednesday as investors react to a $570 million acquisition deal with Voya Financial (VOYA).
Via
InvestorPlace
Why Is Arcturus Therapeutics (ARCT) Stock Up 30% Today?
November 02, 2022
The run-up in ARCT stock is practically unstoppable as two science-focused firms collaborate to develop mRNA technology.
Via
InvestorPlace
Benzinga's Top Ratings Upgrades, Downgrades For November 2, 2022
November 02, 2022
Upgrades
Via
Benzinga
What 4 Analyst Ratings Have To Say About Arcturus Therapeutics
November 02, 2022
Arcturus Therapeutics (NASDAQ:ARCT) has observed the following analyst ratings within the last quarter:
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
November 02, 2022
Gainers Monopar Therapeutics (NASDAQ:MNPR) shares increased by 53.0% to $4.09 during Wednesday's pre-market session. The company's market cap stands at $52.0 million.
Via
Benzinga
Why Rogers Shares Are Trading Sharply Lower; Here Are 33 Stocks Moving Premarket
November 02, 2022
Gainers Avinger, Inc. (NASDAQ: AVGR) rose 32% to $1.36 in pre-market trading. Avinger is expected to release its financial results for the third quarter on Wednesday, November 9, 2022.
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
November 02, 2022
Good morning, trader! It's time to take a look at all of the latest news behind the biggest pre-market stock movers on Thursday!
Via
InvestorPlace
Match Group, Super Micro Computer And Some Other Big Stocks Moving Higher In Today's Pre-Market Session
November 02, 2022
U.S. stock futures traded slightly higher this morning. Here are some big stocks recording gains in today’s pre-market trading session.
Via
Benzinga
Arcturus Announces Collaboration with CSL to Develop and Commercialize Self-amplifying mRNA Vaccines
November 01, 2022
From
Arcturus Therapeutics Holdings Inc.
Via
Business Wire
Arcturus Therapeutics to Report Third Quarter 2022 Financial Results and Provide Corporate Update on November 9, 2022
October 26, 2022
From
Arcturus Therapeutics Holdings Inc.
Via
Business Wire
Micron, Charles River Laboratories And Some Other Big Stocks Moving Higher On Friday
September 30, 2022
U.S. stocks traded slightly higher, with the Nasdaq Composite gaining more than 80 points on Friday. Here are some big stocks recording gains in today’s session.
Via
Benzinga
Arcturus Therapeutics to Attend the Following Investor Conferences
September 27, 2022
From
Arcturus Therapeutics Holdings Inc.
Via
Business Wire
< Previous
1
2
3
4
5
6
7
8
9
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.